A prospective comparative non-randomized study of effectiveness and tolerability of mirabegron compared to solifenacin in a multiple sclerosis population with overactive bladder symptoms.
Latest Information Update: 31 Aug 2020
At a glance
- Drugs Mirabegron (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 31 Aug 2020 New trial record
- 18 Aug 2020 Results published in the Urology